ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Study on the action mechanism of Buyang Huanwu Decoction against ischemic stroke based on S1P/S1PR1/PI3K/Akt signaling pathway

Liu, Wanyi; Zhou, Xin; Zeng, Keqi; Nie, Cong; Huang, Jieyi; Zhu, Lixia; Pei, Die; Zhang, Yingfeng*广州中医药大学; 南方医科大学
Journal of Ethnopharmacology2023-8-10DOI: 10.1016/j.jep.2023.116471
3被引4阅读
引用收藏
分享

摘要

Ethnopharmacological relevance: Ischemic stroke is a common and frequent clinical disease. Recent studies have demonstrated that sphingolipid plays an important role in the pathological process of ischemic stroke. PI3K-Akt is a classic protective signaling pathway of cerebral ischemic injury. After acting on the S1P receptor, S1P can activate the downstream PI3K/Akt signaling pathway and play an anti-cerebral ischemia role. Buyang Huanwu Decoction (BHD) is a traditional Chinese medicine formula used to treat ischemic stroke. However, the mech-anisms of BHD on ischemic stroke remain unclear based on S1P/S1PR1/PI3K/Akt signaling pathway.Aim of the study: The present study is intended to investigate the action mechanism of BHD on ischemic stroke based on the S1P/S1PR1/PI3K/Akt signaling pathway from multiple perspectives. Materials and methods: The BHD lyophilized product was prepared by vacuum freeze-drying method, of which the chemical composition was determined by UPLC-Q-TOF/MS. The mouse permanent middle cerebral artery oc-clusion (pMCAO) model was established by the suture-occluded method. Male KM mice were randomly divided into seven groups: sham group, model group, FTY720 (positive control) group, BHD group, BHD + W146 (se-lective S1PR1 inhibitor) group, SEW2871 (selective S1PR1 agonist) group, and Calycosin group. Each group was administered continuously for 14 days and evaluated with modified neurological severity score (mNSS) and cerebral infarct volume on the 1st, 4th, 7th, and 14th days. The SphK1, SphK2, S1PR1, PI3K, Akt, and p-Akt protein in the prefrontal lobe, hippocampus, and striatum was quantified by Western blot and immunohisto-chemical (IHC) experiment respectively. The qRT-PCR method was employed to evaluate SphK1, SphK2, and S1PR1 mRNA expression in the above tissue.Results: BHD and Calycosin both effectively improved mNSS scores with smaller infarct volumes. The SphK1 level in the prefrontal lobe, hippocampus, and striatum of mice in the BHD group was significantly lower, and SphK2, PI3K, and p-Akt in the hippocampus and striatum were significantly higher than those in the model group. BHD significantly decreased SphK1 mRNA expression in the prefrontal lobe, hippocampus, and striatum, and significantly up-regulated SphK2 mRNA and S1PR1 mRNA expression. Additionally, SphK1 protein expression levels of the prefrontal lobe, hippocampus, and striatum in the BHD group was significantly lower than model group, and SphK2, S1PR1, PI3K, Akt, and p-Akt protein expressions levels were increased obviously. Furthermore, SEW2871 can increase S1PR1 and Akt expression, and up-regulate SphK2 and S1PR1 mRNA expression. The effect of BHD on the expression of S1P/S1PR1/PI3K/Akt signaling pathway-related proteins and mRNA were weakened by BHD + W146. Conclusion: BHD and Calycosin significantly improved the symptoms of neurological deficits in pMCAO mice, reduced the cerebral infarction volume, up-regulated SphK2 and S1PR1 mRNA levels, enhanced SphK2, S1PR1, PI3K, Akt, p-Akt protein expression of the prefrontal lobe, hippocampus and striatum, and down-regulated SphK1 mRNA and protein expression, which may be helpful to clarify the mechanism of BHD through S1P/S1PR1/PI3K/ Akt signaling pathway to protect against cerebral ischemic injury.

学科与关键词

关键词
Buyang Huanwu DecoctionIschemic strokeS1PS1PR1PI3KAkt signaling pathwayAction mechanism
相关
加载中…
  • S1PR3, as a Core Protein Related to Ischemic Stroke, is Involved in the Regulation of Blood-Brain Barrier Damage
    Fan, Xuehui; Chen, Hongping; Xu, Chen; Wang, Yingju; Yin, Pengqi; Li, Meng; Tang, Zhanbin; Jiang, Fangchao; Wei, Wan; Song, Jihe; Li, Guozhong*; Zhong, Di*Frontiers in Pharmacology, 2022, 13: 834948.被引 4
  • Sanpian decoction ameliorates cerebral ischemia-reperfusion injury by regulating SIRT1/ERK/HIF-1α pathway through in silico analysis and experimental validation
    Yang, Tong; Liu, Xiaolu; Zhou, Yue; Du, Lipeng; Fu, Yang; Luo, Yanan; Zhang, Wenli; Feng, Zhitao*; Ge, Jinwen*; Mei, Zhigang*Journal of Ethnopharmacology, 2024, 318: 116898.
  • Connexin 43 Mediated the Angiogenesis of Buyang Huanwu Decoction via Vascular Endothelial Growth Factor and Angiopoietin-1 after Ischemic Stroke
    Zhou, Ying; Zhang, Ya-Xing; Yang, Kai-Ling; Liu, Yu-Lian; Wu, Fang-Hua; Gao, Yu-Rong; Liu, Wei*Chinese Journal of Physiology, 2022, 65(2): 72-79.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Ethnopharmacology
发表日期
2023-08-10
卷期
第 312 卷
页码
116471
DOI
10.1016/j.jep.2023.116471
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81873227]; Natural Science Foundation of Guangdong Province, China [2022A1515220101]

作者

  • L

    Liu, Wanyi (第一作者)

    guangzhou univ chinese med

  • Z

    Zhou, Xin

    guangzhou univ chinese med

查看全部 8 位作者收起作者
  • Z

    Zeng, Keqi

    guangzhou univ chinese med

  • N

    Nie, Cong

    guangzhou univ chinese med

  • H

    Huang, Jieyi

    guangzhou univ chinese med

  • Z

    Zhu, Lixia

    southern med univ

  • P

    Pei, Die

    guangzhou univ chinese med

  • Z

    Zhang, Yingfeng (通讯)

    guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417